10.3389/fimmu.2017.01793 33
We included peer-reviewed randomized controlled trials, meta-analyses, and high-quality narrative or systematic reviews written in English that evaluated the effects of GLP-1 receptor agonists (liraglutide, semaglutide, or related analogues), as well as dual GIP/GLP-1 receptor agonists (such as tirzepatide), exercise training, or their combination on weight loss, body composition, metabolic, or cardiovascular outcomes in adults with obesity or type 2 diabetes
[1] [4] These drugs include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist
Key areas of research: Regenerative Medicine Research Collagen Research Skin Biology Research Wound Healing Models Inflammation Research Immune System Research Extracellular Matrix Research Cellular Signaling Research Angiogenesis Research Connective Tissue Research References The Human Tripeptide GHK and Tissue Remodeling Research Stable Gastric Pentadecapeptide BPC 157 and Wound Healing Thymosin Beta-4 and Tissue Repair Mechanisms KPV Peptide in Gastrointestinal and Inflammatory Research References are provided for research context only and do not constitute medical claims
With its combination of L-carnitine and CLA, it can help you burn fat more effectively, reduce body fat, increase energy levels, reduce muscle soreness, and more
Foods high in protein, fiber, and healthy fats can trigger the release of GLP-1, an important hormone that helps regulate blood sugar levels and promotes a feeling of fullness
